Who owns Immix Biopharma, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IMMX from SEC Form 13F filings across 109 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 109 institutions disclosed 56.2M shares of Immix Biopharma, Inc. worth $579.6M — about 88.2% of shares outstanding; the largest disclosed holder is Jupiter Topco LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
109
13F holders
$579.6M
value, 2026 filers
88.2%
of shares outstanding (56.2M sh)
45
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of IMMX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLCNEW | 9.8M | $100.8M | 0.0% | 15.3% | new |
| 2 | Saturn V Capital Management LP | 4.7M | $48.0M | 6.9% | 7.3% | +26.1% |
| 3 | EVENTIDE ASSET MANAGEMENT, LLC | 3.9M | $40.1M | 0.5% | 6.1% | +52.6% |
| 4 | STATE STREET CORP | 3.0M | $30.9M | 0.0% | 4.7% | +1461.6% |
| 5 | BlackRock, Inc. | 3.0M | $30.8M | 0.0% | 4.7% | +538.4% |
| 6 | Deep Track Capital, LPNEW | 2.8M | $28.6M | 0.4% | 4.4% | new |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | $25.8M | 0.0% | 3.9% | +40.2% |
| 8 | Opaleye Management Inc.NEW | 2.3M | $24.2M | 2.2% | 3.7% | new |
| 9 | MILLENNIUM MANAGEMENT LLC | 2.1M | $21.3M | 0.0% | 3.2% | +18.1% |
| 10 | UBS Group AG | 1.9M | $20.0M | 0.0% | 3% | +2427.4% |
| 11 | MARSHALL WACE, LLP | 1.8M | $18.5M | 0.0% | 2.8% | +9.3% |
| 12 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.7M | $17.9M | 0.0% | 2.7% | +319.3% |
| 13 | WELLINGTON MANAGEMENT GROUP LLPNEW | 1.5M | $15.2M | 0.0% | 2.3% | new |
| 14 | GREAT POINT PARTNERS LLC | 1.3M | $13.2M | 2.5% | 2% | +265.0% |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 1.2M | $12.4M | 0.0% | 1.9% | +159.2% |
| 16 | Velan Capital Investment Management LP | 1.1M | $11.2M | 6.8% | 1.7% | +46.6% |
| 17 | Logos Global Management LP | 1.0M | $10.3M | 0.4% | 1.6% | -18.4% |
| 18 | Bleichroeder LP | 1.0M | $10.3M | 1.8% | 1.6% | 0.0% |
| 19 | FRANKLIN RESOURCES INC | 969,120 | $10.0M | 0.0% | 1.5% | 0.0% |
| 20 | Burkehill Global Management, LP | 544,118 | $5.6M | 0.2% | 0.9% | +85.0% |
| 21 | AMERIPRISE FINANCIAL INCNEW | 518,881 | $5.3M | 0.0% | 0.8% | new |
| 22 | CITADEL ADVISORS LLC | 506,157 | $5.2M | 0.0% | 0.8% | +973.0% |
| 23 | Blue Owl Capital Holdings LP | 437,552 | $4.5M | 0.7% | 0.7% | -20.1% |
| 24 | NORTHERN TRUST CORP | 418,051 | $4.3M | 0.0% | 0.7% | +202.4% |
| 25 | Balyasny Asset Management L.P.NEW | 417,227 | $4.3M | 0.0% | 0.7% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.